Psychiatr. praxi. 2012;13(3):120-124

Effect of a combined psychotherapeutic and psychopharmacologic treatment on a long-term glycemic control

MUDr.Jana Komorousová1, MUDr.Zdeněk Jankovec, Ph.D.2, MUDr.Jiří Podlipný, Ph.D.3
1 Psychiatrická ambulance Plzeň
2 I. interní klinika FN Plzeň, Diabetologické centrum
3 Psychiatrická klinika FN Plzeň

in diabetes mellitus type 1 and 2. A retrospective study

Some mental disorders, especially depression, are more prevalent in patients with diabetes mellitus. Comorbid mental disorders deteriorate

prognosis of diabetes mellitus and alternatively, diabetes mellitus deteriorates the course of mental diseases. Results of existing

research suggest that diabetic patients need a psychiatric intervention in addition to a standard care, nonetheless, the study results are

unequivocal regarding effectiveness of the intervention in glycemic control improvement. The retrospective observation in the presented

study concerns 72 diabetic patients, who were treated by one psychiatrist over the past few years. A comparison of psychiatric

intervation modalities (psychotherapy, psychoactive drug treatmentor a combination of both) in type 1 and type 2 diabetic patients is

presented. No association of mental state improvement and glycemic control improvement was found.

Keywords: diabetes mellitus, psychotherapy, psychoactive drugs, glycemic control

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Komorousová J, Jankovec Z, Podlipný J. Effect of a combined psychotherapeutic and psychopharmacologic treatment on a long-term glycemic control. Psychiatr. praxi. 2012;13(3):120-124.
Download citation

References

  1. Medved V, Jovanovic N, Knapic VP. The comorbidity of diabetes mellitus and psychiatric disorders. Psychiatr Danub. 2009; 21(4): 585-588. Go to PubMed...
  2. Höschl C. Konceptuální model deprese a její léčba. Depresivní stavy. Depresivní nemocný v nepsychiatrických ordinacích. Výběr z přednášek odborného sympózia konaného v květnu 2005 v Praze. Medical Tribune, 2005: 34-37.
  3. Češková E. Deprese a somatická onemocnění. Lékařské listy 4/2004: 16.
  4. Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis.In: Diabetologia. 2006; 49(5): 837-845. Go to original source...
  5. Horáček J, Kuzmiaková M. Je deprese poruchou inzulinových receptorů? Psychiatrie 1997; (3-4): 121-126.
  6. Svačina Š. Metabolické účinky psychofarmak. Triton 2004: 26-27.
  7. Herman E, Praško J, Sefertová D. Konziliární psychiatrie. Galén 2007: 422.
  8. Engum A, Mykletun A, Midthjell K, et al. Depression and Diabetes: A large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in tipe 1 and 2 diabetes. Diabetes Care. 2005; 28(8): 1904-1909. Go to original source... Go to PubMed...
  9. Hermanns N, Kulzer B, Krichbaum M, et al. Affective and anxiety disorders in a German sample of diabetic patients, comorbidity and risc factors. Diab. Med. 2005; 22(3): 293-300. Go to original source... Go to PubMed...
  10. Katon WJ, von Korff M, Lin EH B, et al. The Pathways Study. A randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61: 1042-1049. Go to original source... Go to PubMed...
  11. Lustman PJ, Clouse RE. Deprese u diabetiků - vztah mezi duševním rozpoložením a regulací glykémie. Diabetes Complications - CZ. 2005; 3: 141-150.
  12. McKellar JD, Humphreys K, Piette JD. Depression increases diabetes symptoms by complicating patients' self-care adherence. Diabetes Educ. 2004; 30(3): 485-492. Go to original source... Go to PubMed...
  13. Zhang X, Norris SL, Gregg EW, et al. Depressive symptoms and mortality among persons with and without diabetes. American Journal of Epidemilogy. 2005; 161(7): 652-660. Go to original source... Go to PubMed...
  14. Höschl C. Psychosomatická problematika v endokrinologii. Psychosomatická medicína. Grada Aviceum Praha, 1993: 238.
  15. Busner J, Targum SD. The Clinical Global Impressions Scale: Applying a Research Tool in ClinicalPractice. Psychiatry 2009, ISSN 1550-5952.
  16. Beran J. Základy psychoterapie pro lékaře. Grada 2000: 78.
  17. Lustman PJ, Clouse RE, Nix BD, et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo controlled trial. Arch Gen Psychiatry. 2006; 63(5): 521-529. Go to original source... Go to PubMed...
  18. Echeverry D, Duran P, Bonds C, et al. Effect of pharmacological treatment of depression on A1c and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009; 32(12): 2156-60. Epub 2009 Sept 3. Go to original source... Go to PubMed...
  19. Davies M, Dempster M, Malone A. Do people with diabetes who need to talk want to talk? Diabet. Med. 2006; 23: 917-919. Go to original source... Go to PubMed...
  20. Winkley K, Landau S, Eisler I, Ismail K. Psychological interventions to improve glycaemic control in patients with type 1. diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006; 333: 65. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.